LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (NASDAQ: AGEN), today announced additional details for the Company’s upcoming analyst and institutional investor meeting to be held on Thursday, May 14, 2015, from 4:30 to 6:30 PM Eastern Time in New York City. The event will provide an overview of the Company’s proprietary and partnered pipeline, including its antibody platforms and checkpoint modulator programs, its heat shock protein-based vaccine platform and its saponin-based vaccine adjuvant platform.
Help employers find you! Check out all the jobs and post your resume.
